Ignite Creation Date:
2025-12-24 @ 9:58 PM
Ignite Modification Date:
2026-02-07 @ 3:30 AM
Study NCT ID:
NCT05935332
Status:
TERMINATED
Last Update Posted:
2024-07-22
First Post:
2023-06-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high Asthma
Sponsor:
RAPT Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-05
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-21
Completion Date Type:
ACTUAL
First Submit Date:
2023-06-26
First Submit QC Date:
None
Study First Post Date:
2023-07-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-18
Last Update Post Date:
2024-07-22
Last Update Post Date Type:
ACTUAL